Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population [Phase 1]

View source ↗

Summary

Phase 1 trial of fecal microbiota transplantation in an expanded ulcerative colitis population; study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Alberta | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 1 | Status: NOT_YET_RECRUITING